4 min read
Stroke Models Need Diversity: What Age, Sex, and Comorbidity Change About the Data
Stroke remains one of the highest attrition areas in drug development. Despite decades of preclinical programs showing...
May 26, 2026by MD Biosciences
Stroke remains one of the highest attrition areas in drug development. Despite decades of preclinical programs showing...
May 19, 2026by MD Biosciences
Biomarkers have become the connective tissue of modern drug development. They anchor mechanism of action claims,...
May 12, 2026by MD Biosciences
The attrition rate for analgesic compounds remains stubbornly high. By some estimates, fewer than 2% of preclinical...
May 5, 2026by MD Biosciences
Species selection for GLP toxicology is one of those decisions that quietly shapes everything downstream. It influences...
Apr 28, 2026by MD Biosciences
The last five years have seen remarkable advances in in vitro and ex vivo pain research. Human DRG organoids,...